Cite
Uncovering the mode of action of engineered T cells in patient cancer organoids
MLA
Johanna F. Dekkers, et al. “Uncovering the Mode of Action of Engineered T Cells in Patient Cancer Organoids.” Nature Biotechnology, July 2022. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....5f13e816394f157842a7bd4b7c168dfc&authtype=sso&custid=ns315887.
APA
Johanna F. Dekkers, Maria Alieva, Astrid Cleven, Farid Keramati, Amber K. L. Wezenaar, Esmée J. van Vliet, Jens Puschhof, Peter Brazda, Inez Johanna, Angelo D. Meringa, Heggert G. Rebel, Maj-Britt Buchholz, Mario Barrera Román, Amber L. Zeeman, Sam de Blank, Domenico Fasci, Maarten H. Geurts, Annelisa M. Cornel, Else Driehuis, … Anne C. Rios. (2022). Uncovering the mode of action of engineered T cells in patient cancer organoids. Nature Biotechnology.
Chicago
Johanna F. Dekkers, Maria Alieva, Astrid Cleven, Farid Keramati, Amber K. L. Wezenaar, Esmée J. van Vliet, Jens Puschhof, et al. 2022. “Uncovering the Mode of Action of Engineered T Cells in Patient Cancer Organoids.” Nature Biotechnology, July. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....5f13e816394f157842a7bd4b7c168dfc&authtype=sso&custid=ns315887.